Search Results - Han XH
- Showing 1 - 2 results of 2
-
1
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase I... by Hu XS, Han XH, Yang S, Li N, Wang L, Song YY, Mu H, Shi YK
Published in Cancer Management and Research (2019-05-01)Get full text
Article -
2
